The global aortic endografts sector volume projection was valued at 291.87 thousand units in 2024 and is projected to reach 508.12 thousand units by 2034, registering a CAGR of 5.7% from 2025 to 2034.
Volume Insights Strategic Overview
Allied Market Research announces the release of its comprehensive analysis of the global aortic endografts sector. Aortic endografts are critical implantable devices used in the endovascular repair of aortic aneurysms, helping to reinforce weakened aortic walls and prevent life-threatening ruptures. The rising incidence of abdominal and thoracic aortic aneurysms, along with increased preference for minimally invasive procedures, is driving the global demand for aortic endografts.
The report highlights expanding adoption across hospitals and specialty surgical centers, supported by aging populations, improved diagnostic rates, and enhanced access to advanced vascular treatments. Product volumes have increased in response to next-generation stent graft designs that offer better flexibility, sealing, and anatomical compatibility.
Aortic endografts are also gaining traction due to their role in reducing perioperative complications, minimizing hospital stays, and improving recovery outcomes. Innovations such as branched and fenestrated grafts are enabling more complex aneurysm repairs, thereby boosting clinical success rates. Growing investments in endovascular technologies and training of vascular surgeons are further supporting market growth.
The moderate but steady growth in unit shipments is attributed to the surge in elective procedures, integration of hybrid operating rooms, and reimbursement support across developed regions. The global volume of the aortic endografts sector was 291.87 thousand units in 2024 and is projected to reach 508.12 thousand units by 2034 over the forecast period. The rise in demand for customized graft configurations and improved delivery systems continues to propel the aortic endografts sector volume forecast, making aortic grafts a basis of modern aneurysm treatment.
Regional Aortic endografts Sector Volume Growth
North America dominated the aortic endografts sector volume with 36% share in 2024 and a 4.7% CAGR, while Asia-Pacific, Europe, and LAMEA show strong growth at 6.9%, 5.3% and 5.8% CAGR respectively, driven by rise in hospital admissions due to aneurysm and thus lead to high adoption of aortic endografts.
The regional analysis highlights significant variations in adoption trends and sector potential across the globe for aortic endografts sector volume application. North America led by the U.S. and Canada, is projected to maintain steady growth at a 4.7% CAGR, and Europe follow closely, with 5.3% CAGR with strong growth fueled by an aging population, surge in procedural volume, and technological advancements, thereby driving the aortic endografts sector growth. Asia-Pacific contributed over 32% of the total volume in 2024 and is expected to grow at a CAGR of 6.9%, owing to increasing hospital admissions, a large elderly population, and government initiatives to enhance healthcare infrastructure. LAMEA, with a 5.8% CAGR, is emerging as a high-growth region, benefiting from increased healthcare investments and a rising burden of abdominal & thoracic disease driving the adoption of aortic endografts.
Regional Aortic Endografts Sector Volume Growth
Region | 2024 | 2028 | 2035 | CAGR (2024–2035) |
North America | 104.53 | 126.37 | 166.39 | 4.7% |
Europe | 69.11 | 85.36 | 115.79 | 5.3% |
Asia-Pacific | 94.04 | 123.6 | 183.51 | 6.9% |
LAMEA | 24.19 | 30.44 | 42.44 | 5.8% |
Total | 291.87 | 365.77 | 508.13 | 5.7% |
Source: AMR Analysis
Aortic Endografts Country Sector Sales
U.S. leads the aortic endografts sector volume sales and is projected to reach 90.29 thousand units and 142.86 thousand units by 2035 at 4.7% CAGR respectively, while India (7.2% CAGR) and China (7.7% CAGR) emerge as high-growth sectors driven by growing healthcare expenditure, a high population base, and the shift toward minimally invasive procedures.
The report identifies the U.S. as the largest contributors to the aortic endografts sector in terms of volume. U.S., with its extensive healthcare infrastructure and strong healthcare infrastructure, is projected to reach by 142.86 thousand units by 2035. U.S. remains an important player in North America, which is growing at a steady 4.7% CAGR.
Emerging countries such as China, India and Brazil are expected to drive aortic endografts sector volume significant growth due to their increasing focus on minimally invasive procedures. India, China benefiting from government-led initiatives and the adoption of modern technology, are expected to cite a CAGR of 7.2% and 7.7% the highest among major countries, thereby driving the aortic endografts sector size. Brazil, representing Latin America, is projected to grow at a CAGR of 6.3%, supported by its expanding healthcare industry and favorable policies.
Aortic Endografts Sector Volume Share, By Country, 2025-2034 (Thousand Units)
Country | 2024 | 2028 | 2034 | CAGR (2025-2034) |
U.S. | 90.29 | 108.9 | 142.86 | 4.7% |
Germany | 12.7 | 15.33 | 20.08 | 4.7% |
Japan | 19.17 | 24.66 | 35.43 | 6.3% |
China | 34.12 | 46.29 | 71.92 | 7.7% |
India | 9.27 | 12.34 | 18.66 | 7.2% |
Brazil | 6.38 | 8.21 | 11.82 | 6.3% |
Source: AMR Analysis
Key Highlights by Stakeholders
Highlighting the significance of this report, Anshul Mishra, Associate Vice-President of Allied Market Research, stated, “The growing incidence of aortic aneurysms and the increasing preference for minimally invasive treatment options are creating a favorable environment for aortic endografts. Our latest report sheds light on the evolving clinical and commercial landscape, offering strategic insights for stakeholders seeking to leverage this growth momentum.”
He further added, “Asia-Pacific is emerging as a high-growth region due to its expanding healthcare infrastructure and rising awareness about endovascular treatments. Meanwhile, North America and Europe are benefiting from advancements in fenestrated and branched graft designs, as well as greater surgeon adoption of complex endovascular repair procedures. With this in-depth analysis, we aim to support key decision-makers in aligning their strategies with emerging trends.”
Aortic Endografts Sector Volume Trends
The report also highlights the increasing use of aortic endografts in managing complex aneurysms while improving procedural safety and outcomes. As regulatory bodies and hospitals focus on reducing perioperative complications and enhancing patient outcomes, there is a shift toward low-profile, anatomically adaptive graft systems. Technological innovations such as bioengineered sealing zones, and improved delivery catheters are further boosting clinical success rates and long-term durability.
Moreover, the study analyzes the impact of key healthcare trends, including the rise in geriatric population, growth in prevalence of hypertension and vascular disorders, and disparities in access to specialized care. The demand for aortic endografts is expected to grow not just in tertiary care hospitals but also in outpatient vascular centers as procedures become less invasive and more accessible.
Medical device manufacturers should use the report’s insights to grab new opportunities and plan ahead.
About Allied Market Research
Allied Market Research is a full-service market research and business consulting firm, which provides actionable insights and strategic recommendations to help clients make informed decisions and achieve sustainable growth. For more inquiries, please visit alliedmarketresearch.com
